Related Experiment Videos
The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry
R A Hitchings1, C S Migdal, R Wormald
1Moorfields Eye Hospital, London, UK.
Eye (London, England)
|January 1, 1994
Summary
This study found no significant difference in visual field changes between glaucoma surgery and medical treatment groups, despite differing intraocular pressures. Further investigation into treatment outcomes for glaucoma patients is warranted.
Area of Science:
- Ophthalmology
- Clinical Research
- Glaucoma Management
Background:
- Glaucoma treatment aims to prevent vision loss.
- Surgical, medical, and laser interventions are primary treatment options.
- Assessing long-term visual field progression is crucial for evaluating treatment efficacy.
Purpose of the Study:
- To compare the rate of visual field change in patients with glaucoma undergoing surgery versus medical management.
- To investigate if differences in intraocular pressure correlate with visual field progression across treatment groups.
Main Methods:
- Computer-assisted perimetry (30-2 program) was conducted every six months.
- Pointwise linear regression analysis (Progressor) was applied to patients with at least five visual fields.
- Progression was defined as two consecutive slopes significant at the 0.05 level.
Main Results:
- Forty-eight patients in the surgery group, 40 in the medical group, and 20 in the laser group were analyzed.
- No significant difference in visual field improvement or worsening was observed between the surgery and medical groups.
- This lack of difference persisted despite a statistically significant difference in intraocular pressure between these two groups.
Conclusions:
- Current glaucoma treatments (surgery vs. medical) show comparable long-term visual field outcomes.
- Intraocular pressure differences alone may not fully explain visual field progression rates across different treatment modalities.
- Further research is needed to understand the multifactorial nature of glaucoma progression and optimize treatment strategies.